Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

New England Journal of Medicine

Volumn 383, Issue 2, 2020, Pages 120-128

  Ackermann, Maximilian ^a   Verleden, Stijn E ^f   Kuehnel, Mark ^b,e   Haverich, Axel ^c,e   Welte, Tobias ^d,e   Laenger, Florian ^b,e   Vanstapel, Arno ^f   Werlein, Christopher, M D ^b,e   Stark, Helge ^b,e   Tzankov, Alexandar ^g   Li, William W ^h   Li, Vincent W ^h   Mentzer, Steven J ⁱ   Jonigk, Danny ^b,e  

^a HELIOS KLINIKUM WUPPERTAL   (Germany)

^b Institute of Pathology   (Germany)

^c and Vascular Surgery ^*  (Germany)

^d Clinic of Pneumology   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h The Angiogenesis Foundation   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2;

ADULT; AGED; ALVEOLAR CAPILLARY MICROTHROMBUS; ANGIOGENESIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; CORROSION CASTING; DIFFUSE ALVEOLAR DAMAGE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; FEMALE; FIBRIN DEPOSITION; GENE CONTROL; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLUENZA; INTUSSUSCEPTIVE ANGIOGENESIS; LUNG DISEASE; LUNG EDEMA; LUNG WEIGHT; MALE; MICRO-COMPUTED TOMOGRAPHY; MICROANGIOPATHY; MICROTHROMBUS; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PNEUMOCYTE TYPE 2 HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR ENDOTHELIALITIS; SCANNING ELECTRON MICROSCOPY; THROMBOSIS; ADULT RESPIRATORY DISTRESS SYNDROME; AUTOPSY; BETACORONAVIRUS; COMPARATIVE STUDY; CORONAVIRUS INFECTION; INFLUENZA A VIRUS (H1N1); LUNG; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PANDEMIC; RESPIRATORY FAILURE; VASCULAR ENDOTHELIUM; VERY ELDERLY; VIROLOGY; VIRUS PNEUMONIA;

AGED; AGED, 80 AND OVER; AUTOPSY; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; THROMBOSIS;

EID: 85086722950     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa2015432     Document Type: Article

References (25)

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382: 727-33.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395: 507-13.
3. Raptis CA, Hammer MM, Short RG, et al. Chest CT and coronavirus disease (COVID-19): a critical review of the literature to date. AJR Am J Roentgenol 2020 April 16 (Epub ahead of print).
4. Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med 2017;377: 562-72.
5. Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage - the role of oxygen, shock, and related factors: a review. Am J Pathol 1976;85: 209-28.
6. Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology 2018;72: 516-24.
7. Nicholls JM, Poon LLM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361: 1773-8.
8. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 2020;153: 725-33.
9. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15: 700-4.
10. Menter T, Haslbauer JD, Nienhold R, et al. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology 2020 May 4 (Epub ahead of print).
11. Voltersvik P, Aqrawi LA, Dudman S, et al. Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study. Influenza Other Respir Viruses 2016;10: 525-31.
12. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020 April 15 (Epub ahead of print).
13. Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation 2020 April 15 (Epub ahead of print).
14. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18: 1094-9.
15. Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3, 062 COVID-19 patients: a meta-analysis. J Med Virol 2020 April 15 (Epub ahead of print).
16. Porfidia A, Pola R. Venous thromboembolism in COVID-19 patients. J Thromb Haemost 2020 April 15 (Epub ahead of print).
17. Scholten EL, Beitler JR, Prisk GK, Malhotra A. Treatment of ARDS with prone positioning. Chest 2017;151: 215-24.
18. Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202: 415-24.
19. O'Donnell JS, Sharif K, Emery P, Bridgewood C. McGonagle D. Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated intravascular coagulation. April 2020 (https://www.researchgate.net/ publication/ 340621484 _Why_the_Immune_Mechanisms_of _Pulmonary_Intravascular_Coagulopathy in_COVID -19_ Pneumonia_are _Distinct_from_Macrophage_Activation _Syndrome_with_Disseminated _Intravascular_Coagulation). preprint.
20. Mentzer SJ, Konerding MA. Intussusceptive angiogenesis: expansion and remodeling of microvascular networks. Angiogenesis 2014;17: 499-509.
21. Ackermann M, Stark H, Neubert L, et al. Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. Eur Respir J 2020;55(3): 1900933.
22. Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas and review of autopsy findings from other United States cities. May 7, 2020 (https://www.science direct.com/ science/ article/ pii/ S1054880720300375). preprint.
23. Hoffmann M, Kleine-Weber H, Krueger N, Mueller MA, Drosten C, Poehlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. January 31, 2020 (https://www.biorxiv.org/ content/ 10.1101/ 2020.01.31.929042v1). preprint.
24. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020;367: 1444-8.
25. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395: 1417-8.